Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Bouabdallaoui, Nadia; Tardif, Jean‐Claude; D. Waters, David; J. Pinto, Fausto; P. Maggioni, Aldo; Díaz, Rafael; Berry, Colin; Köenig, Wolfgang; López-Sendón, José; Gamra, Habib; S. Kiwan, Ghassan; Blondeau, Lucie; Orfanos, Andreas; Ibrahim, Réda; C. Grégoire, Jean; Dubé, Marie‐Pierre; Samuel, Michelle; Morel, Olivier; Lim, Pascal; F. Bertrand, Olivier; Kouz, Simon; Guertin, Marie‐Claude; L. L’Allier, Philippe; Roubille, François

doi:10.1093/eurheartj/ehaa659

Public

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Published in European Heart Journal • Aug 4, 2020

Authors:

Nadia Bouabdallaoui

Jean‐Claude Tardif

David D. Waters

Abstract

AIMS: The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the benefits of targeting inflammation after myocardial infarction (MI). We aimed to determine whether time-to-treatment initiation (TTI) influences the beneficial impact of colchicine. METHODS AND RESULTS: In COLCOT, patients ...

Subject

Medicine

Colchicine

Myocardial infarction

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!